{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:37:35Z","timestamp":1773434255814,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00595-020-01960-5","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T01:05:01Z","timestamp":1579655101000},"page":"863-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy"],"prefix":"10.1007","volume":"50","author":[{"given":"Seiichiro","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Soh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Suzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaroh","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Oto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"key":"1960_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","volume":"47","author":"DW Denning","year":"2016","unstructured":"Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47:45\u201368.","journal-title":"Eur Respir J"},{"key":"1960_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1470-2045(08)70255-9","volume":"9","author":"S Vento","year":"2008","unstructured":"Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol. 2008;9:982\u201392.","journal-title":"Lancet Oncol"},{"key":"1960_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1378\/chest.112.2.541","volume":"112","author":"JL Saraceno","year":"1997","unstructured":"Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest. 1997;112:541\u20138.","journal-title":"Chest"},{"issue":"Suppl 3","key":"1960_CR4","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1086\/376526","volume":"37","author":"DW Denning","year":"2003","unstructured":"Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003;37(Suppl 3):S265\u201380.","journal-title":"Clin Infect Dis"},{"key":"1960_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1378\/chest.06-2441","volume":"131","author":"J Camuset","year":"2007","unstructured":"Camuset J, Nunes H, Dombret MC, Bergeron A, Henno P, Philippe B, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007;131:1435\u201341.","journal-title":"Chest"},{"key":"1960_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1183\/09031936.00054810","volume":"37","author":"NL Smith","year":"2011","unstructured":"Smith NL, Denning DW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2011;37:865\u201372.","journal-title":"Eur Respir J"},{"key":"1960_CR7","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/icvts\/ivs412","volume":"15","author":"S Toyooka","year":"2012","unstructured":"Toyooka S, Kiura K, Shien K, Katsui K, Hotta K, Kanazawa S, et al. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis. Interact CardioVasc Thorac Surg. 2012;15:954\u201360.","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"1960_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/icvts\/ivs028","volume":"14","author":"S Toyooka","year":"2012","unstructured":"Toyooka S, Kiura K, Takemoto M, Oto T, Takigawa N, Fujiwara T, et al. Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis. Interact CardioVasc Thorac Surg. 2012;14:565\u20139.","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"1960_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thoraxjnl-2014-206291","volume":"70","author":"C Kosmidis","year":"2015","unstructured":"Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270\u20137.","journal-title":"Thorax"},{"key":"1960_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11864-019-0624-7","volume":"20","author":"DS Bryan","year":"2019","unstructured":"Bryan DS, Donington JS. The role of surgery in management of locally advanced non-small cell lung cancer. Curr Treat Opt Oncol. 2019;20:27.","journal-title":"Curr Treat Opt Oncol"},{"key":"1960_CR11","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1245\/s10434-012-2302-x","volume":"19","author":"K Shien","year":"2012","unstructured":"Shien K, Toyooka S, Kiura K, Matsuo K, Soh J, Yamane M, et al. Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer. Ann Surg Oncol. 2012;19:2685\u201392.","journal-title":"Ann Surg Oncol"},{"key":"1960_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.athoracsur.2016.03.092","volume":"102","author":"H Sato","year":"2016","unstructured":"Sato H, Toyooka S, Soh J, Hotta K, Katsui K, Yamamoto H, et al. The feasibility of median sternotomy with or without thoracotomy for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy. Ann Thorac Surg. 2016;102:985\u201392.","journal-title":"Ann Thorac Surg"},{"key":"1960_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative oncology group. Am J Clin Oncol. 1982;5:649\u201355.","journal-title":"Am J Clin Oncol"},{"key":"1960_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"1960_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bjc.6601624","volume":"90","author":"H Katayama","year":"2004","unstructured":"Katayama H, Ueoka H, Kiura K, Tabata M, Kozuki T, Tanimoto M, et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer. 2004;90:979\u201384.","journal-title":"Br J Cancer"},{"key":"1960_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jjco\/hyy003","volume":"48","author":"G Makimoto","year":"2018","unstructured":"Makimoto G, Kubo T, Oze I, Ohashi K, Hotta K, Tabata M, et al. Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery. Jpn J Clin Oncol. 2018;48:287\u201390.","journal-title":"Jpn J Clin Oncol"},{"key":"1960_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1574-6968.2010.02130.x","volume":"313","author":"E Mowat","year":"2010","unstructured":"Mowat E, Rajendran R, Williams C, McCulloch E, Jones B, Lang S, et al. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol Lett. 2010;313:96\u2013102.","journal-title":"FEMS Microbiol Lett"},{"key":"1960_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejcts.2005.10.043","volume":"29","author":"Y Shiraishi","year":"2006","unstructured":"Shiraishi Y, Katsuragi N, Nakajima Y, Hashizume M, Takahashi N, Miyasaka Y. Pneumonectomy for complex aspergilloma: is it still dangerous? Eur J Cardiothorac Surg. 2006;29:9\u201313.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1960_CR19","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s00595-018-1663-6","volume":"48","author":"S Sugimoto","year":"2018","unstructured":"Sugimoto S, Yamane M, Otani S, Kurosaki T, Okahara S, Hikasa Y, et al. Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients. Surg Today. 2018;48:848\u201355.","journal-title":"Surg Today"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-01960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-020-01960-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-01960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:53:45Z","timestamp":1611104025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-020-01960-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,21]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1960"],"URL":"https:\/\/doi.org\/10.1007\/s00595-020-01960-5","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,21]]},"assertion":[{"value":"29 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Shinichi Toyooka received research grants from Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., and Taiho Pharmaceutical Co., Ltd. Katsuyuki Kiura received research grants from Bristol-Myers Squibb K. K., Chugai Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., and Ono Pharmaceutical Co., Ltd. The other authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}